Literature DB >> 26181318

Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient.

Tatsuo Inoue1, Satoshi Kitai1, Sousuke Hayaishi1, Masatoshi Kudo2.   

Abstract

We describe a case of non-O1/ non-O139 Vibrio cholerae septicemia in a 65-year-old male patient with alcoholic liver cirrhosis. He was admitted due to septic shock from non-O1/ non-O139 V. cholerae. An intravenous empiric antibiotic, ceftriaxone sodium hydrate, was administered together with amikacin sulfate, gamma globulin and dopamine. He was discharged feeling well 17 days after admission. Poor host defense mechanisms as seen in cirrhotic patients seem to be a determinant for systemic infection of non-O1/ non-O139 V. cholerae. Such patients should be warned and educated against eating raw or undercooked seafood to avoid the occurrence of non-O1/non-O139 V. cholerae septicemia.

Entities:  

Keywords:  Cirrhosis; Non-O1/ non-O139 Vibrio cholerae; Septicemia

Year:  2012        PMID: 26181318     DOI: 10.1007/s12328-012-0332-3

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  33 in total

Review 1.  A case of non-O:1 Vibrio cholerae septicemia with meningitis, cerebral abscess and unilateral hydrocephalus in a preterm baby.

Authors:  E A Ismail; M H Shafik; G Al-Mutairi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-08       Impact factor: 3.267

2.  Necrotising fasciitis caused by Vibrio vulnificus in a man with cirrhosis.

Authors:  Chih-Hsin Lee; Chen-Chie Wang; Chung-Tai Yue; Ko-Jen Li; Yao-Kuang Wu
Journal:  Lancet Infect Dis       Date:  2008-06       Impact factor: 25.071

3.  In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.

Authors:  Bo-An Su; Hung-Jen Tang; Yin-Yi Wang; Yung-Ching Liu; Wen-Chien Ko; Cheng-Yi Liu; Yin-Ching Chuang
Journal:  J Microbiol Immunol Infect       Date:  2005-12       Impact factor: 4.399

4.  Bullous cellulitis in cirrhotic patients--a rare but life-threatening infection caused by non-O1, non-O139 Vibrio cholerae bacteraemia.

Authors:  Chih-Jen Yang; Chuan-Sheng Wang; Po-Liang Lu; Tun-Chieh Chen; Yen-Hsu Chen; Ming-Shyan Huang; Chun-Chu Lin; Jhi-Jhu Hwang
Journal:  J Med Microbiol       Date:  2011-02-03       Impact factor: 2.472

5.  A cytotoxin-producing strain of Vibrio cholerae non-O1, non-O139 as a cause of cholera and bacteremia after consumption of raw clams.

Authors:  H Namdari; C R Klaips; J L Hughes
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 6.  Vibrio cholerae bacteremia in a neutropenic patient with non-small-cell lung carcinoma.

Authors:  T Berghmans; F Crokaert; J P Sculier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-09-03       Impact factor: 3.267

7.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

8.  A case of non-O1 and non-O139 Vibrio cholerae septicemia with endophthalmitis in a cirrhotic patient.

Authors:  Chin-Chao Yang; Bor-Jen Lee; Sheng-Shun Yang; Yu-Hui Lin; Ya-Ling Lee
Journal:  Jpn J Infect Dis       Date:  2008-11       Impact factor: 1.362

9.  A prospective study of bacterial infections in patients with cirrhosis.

Authors:  W R Caly; E Strauss
Journal:  J Hepatol       Date:  1993-07       Impact factor: 25.083

10.  Fatal bacteremia due to immotile Vibrio cholerae serogroup O21 in Vientiane, Laos - a case report.

Authors:  Rattanaphone Phetsouvanh; Masami Nakatsu; Eiji Arakawa; Viengmone Davong; Manivanh Vongsouvath; Olay Lattana; Catrin E Moore; Satoshi Nakamura; Paul N Newton
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-04-25       Impact factor: 3.944

View more
  1 in total

Review 1.  Non-serogroup O1/O139 agglutinable Vibrio cholerae: a phylogenetically and genealogically neglected yet emerging potential pathogen of clinical relevance.

Authors:  Bright E Igere; Anthony I Okoh; Uchechukwu U Nwodo
Journal:  Arch Microbiol       Date:  2022-05-14       Impact factor: 2.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.